The size of the Sterile Filtration Market in Latin America was valued at USD 0.74 billion in 2022. It is further estimated to be growing at a CAGR of 8.98% and value USD 1.14 billion by 2027.
Sterilization makes culture media infections free by applying pressure, heat, filtration, and chemical. This process deactivates the infectious protein like prions of the micro-organism and hence results in the infection-free medium.
Smaller pore sizes lower the flow rate; so, to achieve higher total throughput to avoid premature blockage, pre-filters might be used to protect small pore membrane filters. Membrane filters are used in the production process are commonly made from materials such as mixed cellulose ester or Polyethersulfone (PES). The filtration equipment and the filters themselves may be purchased as pre-sterilized disposable units in sealed packaging or must be sterilized by the user, generally by autoclaving at a temperature that does not damage the fragile filter membranes.
Growth in the biopharmaceutical industry, increase in R&D spending, rising incidence of diabetes & kidney failure, growing demand for biopharmaceutical molecules, and increasing purity requirements in the end-user market are driving factors of the market.
However, strict government regulations for validation of the filtration process are the major factor restraining the growth of this market.
This research report on the Latin America Sterile Filtration Market has been segmented and sub-segmented into the following categories:
By Membrane Pore Size:
By End User:
Companies playing a significant role in the Latin America Sterile filtration market include Merck & Co., Inc., 3M, General Electric Company, Pall Corporation, Parker Hannifin Corporation, Sartorius Stedim Biotech Group, Porvair Filtration Group, Sterlitech Corporation, and Starlab Scientific Co., Ltd.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com